Picture of Lakefront Biotherapeutics NV logo

LKFT Lakefront Biotherapeutics NV News Story

0.000.00%
nl flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Brief: Galapagos Says 9m Net Profit Of Period EUR 48.8 Million

Oct 30 (Reuters) - Galapagos NV  GLPG.AS :
    * GALAPAGOS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATE
    * GALAPAGOS NV  - 9M NET PROFIT OF PERIOD EUR 48.8 MILLION

Source text:  ID:nGNX714L0W 
Further company coverage:  GLPG.AS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Lakefront Biotherapeutics NV

See all news